A new study tracking over 5000 patients for up to 10 years reports a significant association of blood A1C levels (often used as a risk factor for pre-diabetes and diabetes) and cognitive decline (in cognition, memory and executive functioning). Importantly, the analysis adjusted for other possible contributors to cognitive decline that can also occur in diabetes patients, such as obesity and depression. Although more work needs to be done to establish just how A1C levels may impact cognitive decline–and eventually, dementia–it seems clear that at least one important strategy is shared for combating both diabetes and cognitive decline: early detection and early management before the onset of the disease lead to far superior outcomes, slowing the progression of symptoms and extending the number of functional, healthy years each individual enjoy.
Check out a nice summary of the study here.
Neurologics’ advanced Brain Mapping and customized neurotraining programs can support early detection and management of cognitive decline! With best-in-field technology and proven results, Neurologics is ready to help you extend the horizons of your healthy life. Come visit us today!